Audicin Secures $1.9M to Embed Neuro-Regulation into Daily Life
April 2, 2026, 9:52 pm
Neurotech innovator Audicin secured $1.9M to scale real-time nervous system regulation. This funding advances its mobile app, a powerful SDK for partner platforms, and a unique offline Sleep Headband. The company harnesses brainwave entrainment, auditory engineering, and music neuroscience. Its technology enhances focus, boosts productivity, aids stress recovery, and improves sleep. Solutions integrate seamlessly with popular wearables. Audicin boasts significant commercial success. It has an $8M sales pipeline across defense, athletic performance, and wellness sectors. This investment boosts market reach and product development, bringing total funding to approximately $3M. Audicin aims to embed background nervous system support into daily life, offering pervasive neuro-wellness.
Audicin, a Finnish neurotech firm, just landed $1.9 million in fresh capital. This investment propels its mission: making real-time nervous system regulation a seamless part of daily existence. The funding round included private investment. Oura ring co-founder Petteri Lahtela also provided follow-on backing. Virpi Tuomivaara also participated. Business Finland’s selective Deep Tech Accelerator contributed substantial support. This program offers phased funding linked to technical and commercial milestones. This latest raise builds on Audicin’s earlier pre-seed round. That initial funding also came from Oura’s founding team. Total capital raised now stands at approximately $3 million.
This financial injection will accelerate commercialization efforts. It targets Audicin's core mobile application. It also supports the innovative Sleep Headband. A key focus is the rollout of Audicin for Apps. This lightweight Software Development Kit (SDK) is a game-changer. It enables digital health, performance, and consumer platforms to integrate real-time regulation protocols. These protocols blend directly into user experiences. The approach differs from traditional wellness tools. It does not require users to carve out dedicated time for recovery.
Audicin's SDK allows sessions to run passively. Biometric signals can trigger them. Time of day or specific in-app events can also initiate support. Imagine recovery support kicking in after intense cognitive tasks. Or before sleep programs. Or during high-stress workflows. The integration requires no new hardware. It positions nervous system support as an effortless part of everyday life. The system pairs with popular wearables. These include Oura, Apple Watch, Garmin, and Whoop. Physiological signals dynamically adapt sessions. These sessions compose original music, precision-engineered binaural frequencies, and immersive spatial sound.
For secure, phone-free environments, Audicin offers a specialized solution. The company pilots a standalone, offline, Bluetooth-free Sleep Headband. This device targets deployments in healthcare and defense settings. It comes with a pre-installed eight-hour recovery program. This program centers on a 1Hz delta protocol. This specific frequency associates with deep sleep states.
Audicin's core technology combines multiple advanced fields. It integrates brainwave entrainment, auditory engineering, and music neuroscience. This blend delivers real-time background listening sessions. These sessions support nervous-system regulation around the clock. The company's strategy focuses on omnipresent support. The nervous system constantly adapts to cognitive load, decisions, and stress signals. Audicin aims to regulate this load in the moment. Not just after the fact. This financing enables scaling into challenging environments. These include phone-restricted settings. It brings capability to platforms people already use.
The company shows robust commercial traction. An established $8 million sales pipeline exists. It spans defense, athletic performance, and wellness clinic segments. Audicin 2.0 launched in late 2025. Since then, the company has grown without paid acquisition. Users increased by 40% in just 12 weeks. iOS revenue more than doubled over the past 90 days. Users demonstrate consistent engagement. They average 5.5 sessions per week. Subscription renewal rates hit 69%. Week-one retention also remains strong. Earned discovery largely drives this growth. Demand for Audicin’s offline device also surges.
Partnerships underscore Audicin's market impact. Allied Federal Solutions collaborates to bring innovative sleep technology to defense and veteran communities. Sleep health is critical for operational readiness. It impacts recovery and long-term wellness for service members. Audicin’s platform offers a promising approach. It improves sleep outcomes through scalable, technology-driven solutions. These support clinical research and broader wellness initiatives. Mamamoon, a digital postpartum support platform, also integrated Audicin. It offers guided recovery programs for new mothers. The audio journeys promote deep rest and wellbeing. They enrich the postpartum experience and engagement.
Audicin's design avoids dependence on user effort or ideal conditions. It functions more like infrastructure. It operates during work, rest, and in restricted environments. This sets it apart from tools demanding dedicated wellness time. This infrastructure approach holds strong potential. It applies to enterprise deployments. It also extends through Audicin for Apps. Platforms increasingly integrate real-time nervous system support directly into their products.
Research and product development are led by Dr. Victoria Williamson. She is Co-founder and Chief Scientist. Dr. Williamson is a music psychologist and neuroscientist. Her work focuses on sound's influence on the brain and nervous system. A distinguished Medical Advisory Board supports the company. It spans applied physiology, clinical practice, and wearable analytics. Members include Dr. Hannu Kinnunen, former Chief Scientific Officer at Oura. Eight-time world champion Joel Naukkarinen, MD, also serves. Dr. Jenni Hyysalo completes the board.
Audicin, founded in Finland in 2022, develops leading neurotechnology. Its mission targets real-time stress recovery and sleep. It achieves this through brainwave-entrainment audio protocols. These protocols ground themselves in auditory neuroscience and music psychology. The Audicin app pairs with wearables for personalized recovery sessions. The offline headband device enables use in secure, phone-free environments. Audicin for Apps provides an SDK. This allows third-party platforms to embed recovery protocols. The company's commercial operations base in Austin, Texas. This strategic location facilitates its go-to-market initiatives. The future sees Audicin expanding its reach. It aims to make nervous system health an intrinsic part of modern life.
Audicin, a Finnish neurotech firm, just landed $1.9 million in fresh capital. This investment propels its mission: making real-time nervous system regulation a seamless part of daily existence. The funding round included private investment. Oura ring co-founder Petteri Lahtela also provided follow-on backing. Virpi Tuomivaara also participated. Business Finland’s selective Deep Tech Accelerator contributed substantial support. This program offers phased funding linked to technical and commercial milestones. This latest raise builds on Audicin’s earlier pre-seed round. That initial funding also came from Oura’s founding team. Total capital raised now stands at approximately $3 million.
This financial injection will accelerate commercialization efforts. It targets Audicin's core mobile application. It also supports the innovative Sleep Headband. A key focus is the rollout of Audicin for Apps. This lightweight Software Development Kit (SDK) is a game-changer. It enables digital health, performance, and consumer platforms to integrate real-time regulation protocols. These protocols blend directly into user experiences. The approach differs from traditional wellness tools. It does not require users to carve out dedicated time for recovery.
Audicin's SDK allows sessions to run passively. Biometric signals can trigger them. Time of day or specific in-app events can also initiate support. Imagine recovery support kicking in after intense cognitive tasks. Or before sleep programs. Or during high-stress workflows. The integration requires no new hardware. It positions nervous system support as an effortless part of everyday life. The system pairs with popular wearables. These include Oura, Apple Watch, Garmin, and Whoop. Physiological signals dynamically adapt sessions. These sessions compose original music, precision-engineered binaural frequencies, and immersive spatial sound.
For secure, phone-free environments, Audicin offers a specialized solution. The company pilots a standalone, offline, Bluetooth-free Sleep Headband. This device targets deployments in healthcare and defense settings. It comes with a pre-installed eight-hour recovery program. This program centers on a 1Hz delta protocol. This specific frequency associates with deep sleep states.
Audicin's core technology combines multiple advanced fields. It integrates brainwave entrainment, auditory engineering, and music neuroscience. This blend delivers real-time background listening sessions. These sessions support nervous-system regulation around the clock. The company's strategy focuses on omnipresent support. The nervous system constantly adapts to cognitive load, decisions, and stress signals. Audicin aims to regulate this load in the moment. Not just after the fact. This financing enables scaling into challenging environments. These include phone-restricted settings. It brings capability to platforms people already use.
The company shows robust commercial traction. An established $8 million sales pipeline exists. It spans defense, athletic performance, and wellness clinic segments. Audicin 2.0 launched in late 2025. Since then, the company has grown without paid acquisition. Users increased by 40% in just 12 weeks. iOS revenue more than doubled over the past 90 days. Users demonstrate consistent engagement. They average 5.5 sessions per week. Subscription renewal rates hit 69%. Week-one retention also remains strong. Earned discovery largely drives this growth. Demand for Audicin’s offline device also surges.
Partnerships underscore Audicin's market impact. Allied Federal Solutions collaborates to bring innovative sleep technology to defense and veteran communities. Sleep health is critical for operational readiness. It impacts recovery and long-term wellness for service members. Audicin’s platform offers a promising approach. It improves sleep outcomes through scalable, technology-driven solutions. These support clinical research and broader wellness initiatives. Mamamoon, a digital postpartum support platform, also integrated Audicin. It offers guided recovery programs for new mothers. The audio journeys promote deep rest and wellbeing. They enrich the postpartum experience and engagement.
Audicin's design avoids dependence on user effort or ideal conditions. It functions more like infrastructure. It operates during work, rest, and in restricted environments. This sets it apart from tools demanding dedicated wellness time. This infrastructure approach holds strong potential. It applies to enterprise deployments. It also extends through Audicin for Apps. Platforms increasingly integrate real-time nervous system support directly into their products.
Research and product development are led by Dr. Victoria Williamson. She is Co-founder and Chief Scientist. Dr. Williamson is a music psychologist and neuroscientist. Her work focuses on sound's influence on the brain and nervous system. A distinguished Medical Advisory Board supports the company. It spans applied physiology, clinical practice, and wearable analytics. Members include Dr. Hannu Kinnunen, former Chief Scientific Officer at Oura. Eight-time world champion Joel Naukkarinen, MD, also serves. Dr. Jenni Hyysalo completes the board.
Audicin, founded in Finland in 2022, develops leading neurotechnology. Its mission targets real-time stress recovery and sleep. It achieves this through brainwave-entrainment audio protocols. These protocols ground themselves in auditory neuroscience and music psychology. The Audicin app pairs with wearables for personalized recovery sessions. The offline headband device enables use in secure, phone-free environments. Audicin for Apps provides an SDK. This allows third-party platforms to embed recovery protocols. The company's commercial operations base in Austin, Texas. This strategic location facilitates its go-to-market initiatives. The future sees Audicin expanding its reach. It aims to make nervous system health an intrinsic part of modern life.